We Extend our Global Market Access Capabilities Through the Acquisition of Wellmera

Expanded market access expertise strengthens Alira Health’s suite of healthcare advisory services

 

News
Published on:
December 17, 2019

FRAMINGHAM, MA, USA – December 17, 2019 – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, announced that it has acquired Wellmera, a healthcare consulting firm headquartered in Basel, Switzerland specializing in market access for the pharmaceutical and biotechnology industries. The acquisition will bring global expertise in market access, pricing and reimbursement, health economics, and real-world evidence to Alira Health’s suite of healthcare advisory services.

The collective organization will advance Alira Health’s mission of enabling healthcare transformation by supporting clients across their product and corporate life cycles, with services in product development, regulatory, clinical, strategic consulting, and transaction advisory. The Wellmera team brings a wealth of experience in helping clients develop evidence, devise pricing and market access approaches, and provide tailored strategies to local client affiliates in preparation for pricing and reimbursement negotiations around the world, with a focus on European markets.

We are thrilled to welcome Wellmera and their incredible team to Alira Health. This acquisition is an important step in achieving our vision of offering a full continuum of services, particularly in the critical areas of regulatory, clinical and market access,” said Gabriele Brambilla, CEO of Alira Health. “These expanded services will help us to deliver even greater value to our clients as they develop and bring to market the next generation of healthcare innovations.

The Wellmera team is excited to join Alira Health,” says Jean-François Ricci, PharmD PhD, President and Principal at Wellmera. “This partnership allows us to bring our market access expertise to a larger global organization, helping us to impact patient care on an even greater scale. We see many synergies with Alira Health’s lifecycle approach, and feel a strong connection in our passion for healthcare, our quality of work, and the culture of our teams.”

Jean-François Ricci will become Executive Vice President of Market Access and will lead Alira Health’s Market Access practice, covering pharma, biotech, and digital health in Europe and the United States.

About Wellmera:

Wellmera is a dynamic international consulting firm focused on market access, pricing and reimbursement, health economics, and real-world evidence. We help life sciences companies demonstrate value, optimize patient access, and realize the commercial opportunity for their products throughout the lifecycle.

Wellmera was established in 2011 in Basel, Switzerland and expanded in early 2018 to the US with offices in Cambridge, MA, and San Francisco, CA, leveraging synergies for global clients between Europe and the US.

To learn more about Alira Health's Market Access practice

Click here

Related news

Market Access MedTech
Multimedia February 26, 2021
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
Join host Kenny Carberry, Associate Director of Clinical Development, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO(...)
MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
MedTech Pharma
News February 4, 2021
2020 Year in Review
With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)
M&A Pharma
News December 20, 2020
We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS
We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.
Pharma
News December 15, 2020
Welcome Daniela Sica, Vice President, Business Development, Pharma and Biotech
We are pleased to announce that Daniela Sica has joined the firm as Vice President, Business Development, Pharma and Biotech.
Market Access MedTech
Publications December 5, 2020
Critical Success Factors in Market Access
Today’s MedTech market is more concentrated than ever, with critical factors that need to be examined to advance a new product.
Market Access Pharma
Publications November 2, 2020
WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies
The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.